[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Vascular Stent Market, 2020-2026

March 2020 | 91 pages | ID: G213CD81327CEN
Gen Consulting Company

US$ 3,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Vascular stents are small tubular scaffolds widely used in the treatment of arterial stenosis (narrowing of the vessel) to prevent acute vessel closure and late restenosis in a variety of vessels such as coronary arteries. According to Gen Consulting Company, global vascular stent market is expected to reach USD 10,984.67 million by the end of 2026, expanding at a CAGR of 6.68% over the forecast period i.e. 2020-2026. Increasing number of angioplasty procedures, rising burden of vascular diseases and the rising geriatric population are the major factors driving the growth of the market.

The vascular stent market is segmented on the basis of product, type, application, and region. The report offers a breakdown of market shares by product, including Coronary Stents, Peripheral Vascular Stents, Carotid Artery Stents, Renal Artery Stents. Based on type, the market for vascular stent is segmented into Bare Metal Stents (BMS), Bioabsorbable Stents (BAS), Covered Stents, Drug Eluting Stents (DES). By application, the vascular stent market is classified into Hospitals, Ambulatory Surgery Centers (ASCs). On the basis of region, the vascular stent industry is analyzed across North America, Europe, Asia-Pacific, South America and MEA (the Middle East, and Africa).

By Product:
  • Coronary Stents
  • Peripheral Vascular Stents
  • Carotid Artery Stents
  • Renal Artery Stents
By Type:
  • Bare Metal Stents (BMS)
  • Bioabsorbable Stents (BAS)
  • Covered Stents
  • Drug Eluting Stents (DES)
By Application:
  • Hospitals
  • Ambulatory Surgery Centers (ASCs)
By region, the market is analyzed across North America, Asia Pacific, Europe, Middle East & Africa and South America. This report forecasts revenue growth at global, regional & country level from 2020 to 2026.
  • North America (U.S., Canada, Mexico, etc.)
  • Asia-Pacific (China, Japan, India, Korea, Australia, Indonesia, Taiwan, Thailand, etc.)
  • Europe (Germany, UK, France, Italy, Russia, Spain, etc.)
  • Middle East & Africa (Turkey, Saudi Arabia, Iran, Egypt, Nigeria, UAE, Israel, South Africa, etc.)
  • South America (Brazil, Argentina, Colombia, Chile, Venezuela, Peru, etc.)
The market research report covers the analysis of key stake holders of the vascular stent market. Some of the leading players profiled in the report include:
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group Incorporated
  • Getinge AB
  • Kyoto Medical Planning Co., Ltd.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Sahajanand Medical Technologies Pvt. Ltd.
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.
*list is not exhaustive, request free sample to get a complete list of companies

The base year of the study is 2019, and forecasts run up to 2026.

Research Objective
  • To analyze and forecast the market size of global vascular stent market.
  • To classify and forecast global vascular stent market based on product, type, application, and region.
  • To identify drivers and challenges for global vascular stent market.
  • To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in global vascular stent market.
  • To conduct pricing analysis for global vascular stent market.
  • To identify and analyze the profile of leading players operating in global vascular stent market.
The report is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities. Key target audience are:
  • Manufacturers of vascular stent
  • Raw material suppliers
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to vascular stent
PART 1. INTRODUCTION

1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic on Global Economy
4.5 Porter's Five Forces Analysis
  4.5.1 Bargaining Power of Suppliers
  4.5.2 Bargaining Power of Consumers
  4.5.3 Threat of New Entrants
  4.5.4 Threat of Substitute Products and Services
  4.5.5 Degree of Competition

PART 5. GLOBAL MARKET FOR VASCULAR STENT BY PRODUCT

5.1 Market Overview
5.2 Coronary Stents
  5.2.1 Market Size and Forecast
5.3 Peripheral Vascular Stents
  5.3.1 Market Size and Forecast
5.4 Carotid Artery Stents
  5.4.1 Market Size and Forecast
5.5 Renal Artery Stents
  5.5.1 Market Size and Forecast

PART 6. GLOBAL MARKET FOR VASCULAR STENT BY TYPE

6.1 Market Overview
6.2 Bare Metal Stents (BMS)
  6.2.1 Market Size and Forecast
6.3 Bioabsorbable Stents (BAS)
  6.3.1 Market Size and Forecast
6.4 Covered Stents
  6.4.1 Market Size and Forecast
6.5 Drug Eluting Stents (DES)
  6.5.1 Market Size and Forecast

PART 7. GLOBAL MARKET FOR VASCULAR STENT BY APPLICATION

7.1 Market Overview
7.2 Hospitals
  7.2.1 Market Size and Forecast
7.3 Ambulatory Surgery Centers (ASCs)
  7.3.1 Market Size and Forecast

PART 8. GLOBAL MARKET FOR VASCULAR STENT BY GEOGRAPHY

8.1 Overview
  8.1.1 Market Size and Forecast
8.2 North America
  8.2.1 Market Size and Forecast
  8.2.2 North America: Vascular Stent Market by Country
    8.2.2.1 United States
    8.2.2.2 Canada
    8.2.2.3 Mexico
8.3 Europe
  8.3.1 Market Size and Forecast
  8.3.2 Europe: Vascular Stent Market by Country
    8.3.2.1 Germany
    8.3.2.2 France
    8.3.2.3 United Kingdom
    8.3.2.4 Italy
    8.3.2.5 Rest of The Europe
8.4 Asia-Pacific
  8.4.1 Market Size and Forecast
  8.4.2 Asia-Pacific: Vascular Stent Market by Country
    8.4.2.1 China
    8.4.2.2 India
    8.4.2.3 Japan
    8.4.2.4 South Korea
    8.4.2.5 ASEAN Countries
8.5 Middle East and Africa (MEA)
  8.5.1 Market Size and Forecast
  8.5.2 MEA: Vascular Stent Market by Country
    8.5.2.1 Saudi Arabia
    8.5.2.2 South Africa
    8.5.2.3 Turkey
8.6 South America
  8.6.1 Market Size and Forecast
  8.6.2 South America: Vascular Stent Market by Country
    8.6.2.1 Brazil
    8.6.2.2 Argentina
    8.6.2.3 Rest of South America

PART 9. COMPETITIVE LANDSCAPE

9.1 Market Share
9.2 Mergers & Acquisitions, Agreements, Collaborations and Partnerships

PART 10. KEY COMPETITOR PROFILES

10.1 Abbott Laboratories
10.2 B. Braun Melsungen AG
10.3 Becton, Dickinson and Company
10.4 BIOTRONIK SE & Co. KG
10.5 Boston Scientific Corporation
10.6 Cardinal Health, Inc.
10.7 Cook Group Incorporated
10.8 Getinge AB
10.9 Kyoto Medical Planning Co., Ltd.
10.10 Lepu Medical Technology (Beijing) Co., Ltd.
10.11 Medtronic plc
10.12 MicroPort Scientific Corporation
10.13 Sahajanand Medical Technologies Pvt. Ltd.
10.14 Terumo Corporation
10.15 W. L. Gore & Associates, Inc.
*LIST IS NOT EXHAUSTIVE

PART 11. PATENT ANALYSIS

11.1 Patent Statistics
11.2 Regional Analysis
11.3 Trends Analysis

DISCLAIMER

ABOUT GEN CONSULTING COMPANY


More Publications